French Pharmaceutical Laboratories Expand Clinical Research Investments in Advanced Oncology and Immunotherapy Treatments
Major pharmaceutical companies and research institutions based in Paris and Lyon announced a multi-million-euro funding initiative to accelerate clinical trials for targeted cancer therapies and cellular immunotherapies, aiming to strengthen France’s competitiveness in biotechnology and life sciences.